Two Nigerian States (Plateau and Nasarawa) Have Eliminated Transmission of Human Onchocerciasis—A Report of Post-Ivermectin Mass Drug Administration Surveillance

Author:

Miri Emmanuel S.1,Eigege Abel1,Kahansim Barminas1,Nwodu Kenrick1,Sambo Yohana1,Mancha Bulus1,Adelamo Solomon1,Umaru John1,Kadimbo Jonathan2,Danboyi Jacob3,Mafuyai Hayward4,Makata Emeka5,Akpan Nse5,Akilah Joel5,Igbe Michael5,Coalson Jenna6,Rakers Lindsay6,Griswold Emily6,Unnasch Thomas R.7,Nwoke B. E. B.8,Noland Gregory S.6,Richards Frank O.6

Affiliation:

1. The Carter Center Nigeria, Jos, Nigeria;

2. Plateau State Ministry of Health, Jos, Nigeria;

3. Nasarawa State Ministry of Health, Lafia, Nigeria;

4. University of Jos, Jos, Nigeria;

5. Department of Public Health, Federal Ministry of Health, Abuja, Nigeria;

6. The Carter Center, Atlanta, Georgia;

7. University of South Florida, Tampa, Florida;

8. Imo State University, Owerri, Nigeria

Abstract

ABSTRACT. Transmission of Onchocerca volvulus (causing “river blindness”) was interrupted in two states of Nigeria (Plateau and Nasarawa) in 2017 in accordance with 2016 WHO guidelines. Ivermectin mass drug administration was halted in January 2018, and posttreatment surveillance activities were conducted over a 3-year period. Vector Simulium damnosum s.l. flies were collected during the 2019 (39 sites) and 2020 (42 sites) transmission seasons. Head pools were tested by polymerase chain reaction for the presence of third-stage O. volvulus larvae; 15,585 flies were all negative, demonstrating an infective rate of < 1/2,000 with 95% confidence. In 2021, the Nigerian Federal Ministry of Health declared the two-state area as having eliminated transmission. Plateau and Nasarawa states are the first of 30 endemic states in Nigeria to have met the WHO criteria for onchocerciasis elimination. Post-elimination surveillance will need to continue given the risk of reintroduction of transmission from neighboring states.

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3